You searched for viral vector - Page 34 of 53

News and Trends 27 Jul 2022

T-cell therapy company AlloVir set to raise $126.6M

…investments equaled $172.7 million. About AlloVir AlloVir is a late clinical-stage cell therapy company with a focus on restoring natural immunity against life-threatening viral diseases in pediatric and adult patients…

July 27, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 4 Mar 2016

This Megavirus has its own CRISPR-like Defense System

…What is viral immunity? What is life? What is CRISPR? Well, for the last question, you should read our review on CRISPR. As for the rest, you might look for…

March 4, 2016 - 3 minutesmins - By Denise Neves Gameiro

Best in Biotech 28 Jan 2020

10 Scientists Behind Modern Biotech You Probably Don’t Know

…called T-killer cells have the ability to recognize viral subtypes, a principle now being used to develop vaccines against a variety of infections including influenza and HIV. She was asked…

January 28, 2020 - 8 minutesmins - By Helen Albert

Best in Biotech 3 Jan 2017

10 Hot European Biotechs to Observe in 2017 🚀

…is currently running a second trial to better understand how the molecule targets the viral reservoirs. First results are expected in early 2017 und will indicate what strategy the company…

January 3, 2017 - 5 minutesmins - By Philip Hemme

News and Trends 26 Apr 2023

20Med Therapeutics and Touchlight collaborating on novel vaccine delivery platform

20Med Therapeutics, a company working on non-viral delivery and development of gene therapies and vaccines, and Touchlight, a biotechnology company pioneering enzymatic DNA production to enable the genetic medicine revolution,…

April 26, 2023 - 2 minutesmins - By Jim Cornall

News and Trends 1 Jul 2016

BMS to combine Immuno-Oncology Blockbuster with Oxford Biotech

Oxfordshire based PsiOxus will team up with the Immuno-Oncology Giant, Bristol-Myers Squibb, to test the combinatorial effect of their blockbuster drug with an Oncolytic viral therapy in late-stage cancer patients….

July 1, 2016 - 3 minutesmins - By Dani Bancroft

News and Trends 29 Apr 2022

Denmark Recruits Lifebit to Boost Personalized Medicine with Genomics

…federated approach include DNAstack’s Viral AI, which is designed to improve the surveillance of viral pathogens, and the Digital Europe Programme, which aims to improve health data sharing across the…

April 29, 2022 - 3 minutesmins - By Jonathan Smith

News and Trends 8 Feb 2018

GSK’s Company Starts Phase III Trials with Two-Drug HIV Treatment

ViiV Healthcare has just started a clinical trial to test if its two-drug regimen for HIV can work as well as current three-drug HIV treatment. Most antiretroviral treatments used to…

February 8, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 26 Oct 2022

New UK spinout VacV Biotherapeutics emerges from stealth to work on cancer immunotherapies

VacV Biotherapeutics, a cancer immunotherapy company developing innovative viral-based therapies, emerged from stealth mode today to advance its pipeline of pre-clinical assets with best-in-class potential, towards the clinic. VacV Biotherapeutics…

October 26, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 25 Apr 2016

Scottish Biopharma begins Cell Therapy trials for Late-Stage Cancer

…is developing cell-based therapies for cancer and severe viral infection. These therapies are based on γδ T-cells, which can recognise and target specific structures on the cell surface – specifically…

April 25, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 21 Nov 2016

One Antibody to Neutralize 98% of All HIV Strains: Closer to a Cure?

A new hope for HIV: a single antibody that can target nearly all viral strains at once. What does it mean for the search of a global cure? Last week,…

November 21, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 11 Apr 2023

Intracellular drug delivery startup Vitarka Therapeutics raises £1.27M

Vitarka Therapeutics, which focuses on non-viral drug delivery technology, has raised £1.27 million ($1.58 million) in equity from venture capital firm SOSV, the UK Innovation & Science Seed Fund (UK12S)…

April 11, 2023 - 2 minutesmins - By Jim Cornall

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: viral vector

T-cell therapy company AlloVir set to raise $126.6M

This Megavirus has its own CRISPR-like Defense System

10 Scientists Behind Modern Biotech You Probably Don’t Know

10 Hot European Biotechs to Observe in 2017 🚀

20Med Therapeutics and Touchlight collaborating on novel vaccine delivery platform

BMS to combine Immuno-Oncology Blockbuster with Oxford Biotech

Denmark Recruits Lifebit to Boost Personalized Medicine with Genomics

GSK’s Company Starts Phase III Trials with Two-Drug HIV Treatment

New UK spinout VacV Biotherapeutics emerges from stealth to work on cancer immunotherapies

Scottish Biopharma begins Cell Therapy trials for Late-Stage Cancer

One Antibody to Neutralize 98% of All HIV Strains: Closer to a Cure?

Intracellular drug delivery startup Vitarka Therapeutics raises £1.27M

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!